pain in knee. Pain in limb
Conditions
Interventions
Intervention 1: At the end of the surgery in group 1:intra-articular injection of 8 ml bupivacaine 0.5 % with 5 mg morphine will be done. Intervention 2: At the end of the surgery in group 2: int
Prevention
Placebo
At the end of the surgery in group 1:intra-articular injection of 8 ml bupivacaine 0.5 % with 5 mg morphine will be done
At the end of the surgery in group 2: intra-articular injection of 8ml bupivacaine 0.5 % with 40 mg methylprednisolone will be done
At the end of the surgery in group 3: intra-articular injection of 8 ml bupivacaine 0.5 % with 1 ml distilled water will be done
Sponsors
Vice Chancellor for research of Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients 20–80 years old; with American Society of Anesthesiologists (ASA) physical status I or II; scheduled for arthroscopic knee surgery. Exclusion criteria: Patient with neuropathic pain; neurologic deficit in respective organ; surgical history on respective knee; any allergy to used drug; BMI>40; Presence of underlying diseases (cardiac, renal, arthritis & diabetes); chronic pain; coagulopathy; opium addiction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain. Timepoint: 1, 2, 6, 12, 18 and 24 hours after surgery. Method of measurement: Score of pain in Visual analog scale (VAS).;Opioid consumption. Timepoint: During 24 hours after operation. Method of measurement: Mg of Pethidine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: During 24 hrs after the surgery. Method of measurement: Asking the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hoda Shehamat
Qazvin University of Medical Sciences
Outcome results
None listed